Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1477-9560
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study ; volume:16 ; number:1 ; day:4 ; month:12 ; year:2018 ; pages:1-12 ; date:12.2018
Thrombosis journal ; 16, Heft 1 (4.12.2018), 1-12, 12.2018

Creator
Willmann, Stefan
Thelen, Kirstin
Kubitza, Dagmar
Lensing, Anthonie W. A.
Frede, Matthias
Coboeken, Katrin
Stampfuss, Jan
Burghaus, Rolf
Mück, Wolfgang
Lippert, Jörg
Contributor
SpringerLink (Online service)

DOI
10.1186/s12959-018-0185-1
URN
urn:nbn:de:101:1-2019010821144838316948
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.01.20252025, 9:28 AM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Willmann, Stefan
  • Thelen, Kirstin
  • Kubitza, Dagmar
  • Lensing, Anthonie W. A.
  • Frede, Matthias
  • Coboeken, Katrin
  • Stampfuss, Jan
  • Burghaus, Rolf
  • Mück, Wolfgang
  • Lippert, Jörg
  • SpringerLink (Online service)

Other Objects (12)

Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals

Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life

Interspecies extrapolation by physiologically based pharmacokinetic modeling

Interspecies extrapolation by physiologically based pharmacokinetic modeling

Human physiologically based pharmacokinetic model for propofol

Human physiologically based pharmacokinetic model for propofol

Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice

Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice

Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations

Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations

Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review

Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach

Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach

Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling

Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling

Adapting physiologically-based pharmacokinetic models for machine learning applications

Adapting physiologically-based pharmacokinetic models for machine learning applications

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances

Related objects